NR

Nilu Ranjan

Active Director Director DIN 08906756
DIN 08906756 First appointment Oct 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Nilu Ranjan

Data last updated:

Nilu Ranjan is a Director at Sison Health Care Private Limited (since 2020). The company operates in Trading. Sison Health Care Private Limited reported revenue of ₹16.7 Lakh (FY 2025).

DIN 08906756
Primary Designation Director
Industry Trading
First Appointment 06 Oct 2020
Oldest Company Age 6 yrs
Largest company Sison Health Care Private Limited · ₹16.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sison Health Care Private Limited U51909RJ2020PTC071371
Director06 Oct 20202020₹16.7 Lakh (FY 2025)Active

Board colleagues of Nilu Ranjan

Directorship timeline

Open interactive timeline →
Sison Health Care Private Limited
Premium access

Shareholding and investment profile for Nilu Ranjan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilu Ranjan

Nilu Ranjan currently holds 1 directorship: Sison Health Care Private Limited (Director, since 06 Oct 2020, revenue ₹16.7 Lakh (FY 2025)).

Nilu Ranjan was first appointed on 06 Oct 2020 as Director at Sison Health Care Private Limited.

The current boards of Nilu Ranjan's companies include Bikermaditya Kumar (Sison Health Care Private Limited), Reena Sharma (Sison Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available